Cargando…

Late-onset pulmonary complications among survivors of coronavirus Disease 2019

OBJECTIVES: To assess the late-onset pulmonary complications among survivors of coronavirus disease 2019. METHODS: The cross-sectional analytical study was conducted in the department of Pulmonology, Sir Ganga Ram Hospital Lahore between October 2020 and March 2021. Total 288 patients visiting the h...

Descripción completa

Detalles Bibliográficos
Autores principales: Baig, Mirza Muhammad Ayub, Adnan, Muhammad, Baig, Muhammad Usman, Ramzan, Zohaib
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364300/
https://www.ncbi.nlm.nih.gov/pubmed/37492317
http://dx.doi.org/10.12669/pjms.39.4.6302
Descripción
Sumario:OBJECTIVES: To assess the late-onset pulmonary complications among survivors of coronavirus disease 2019. METHODS: The cross-sectional analytical study was conducted in the department of Pulmonology, Sir Ganga Ram Hospital Lahore between October 2020 and March 2021. Total 288 patients visiting the hospital 12-week after recovery from COVID-19 enrolled using convenience sampling. After excluding patients (n=61) with a history of previous respiratory symptoms before the development of COVID-19, data from 227 patients was subjected to final analysis. Chest X-ray (CXR) was used to evaluate lung condition. RESULTS: Participation of middle-aged adults (54.6%) was higher than older (38.3%) and young adults (7.0%). The percentage of males was 55.5% and smokers was 29.1%. Dyspnea was the most common complication as 80.0% patients had moderate to severe dyspnea while chronic cough was 78.0% and lung fibrosis (LF) was 13.2%. The chances of LF increased with the rise in age (p-value 0.033). However, the distribution of LF was similar between males and females. The frequency of lung fibrosis in smokers was 3-time higher than among non-smokers (24.2 vs. 8.7%; p-value 0.003). The patients with LF were more dependent on O2 as compared to the patients without LF (p-value < 0.001). The frequency of tachycardia was significantly different between patients with and without LF (all p-values < 0.05). CONCLUSION: LF is a common late-onset pulmonary complication of COVID-19 and is associated with old age, smoking, O(2) dependency, tachycardia, and severe dyspnea.